Compare SPRY & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | NEOG |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 1989 |
| Metric | SPRY | NEOG |
|---|---|---|
| Price | $10.95 | $9.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $31.25 | $8.83 |
| AVG Volume (30 Days) | 1.6M | ★ 3.6M |
| Earning Date | 11-10-2025 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $142,772,000.00 | ★ $886,886,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $127.81 | $1.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5459.66 | N/A |
| 52 Week Low | $6.66 | $3.87 |
| 52 Week High | $18.90 | $13.41 |
| Indicator | SPRY | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 85.55 |
| Support Level | $10.85 | $6.89 |
| Resistance Level | $11.43 | $7.51 |
| Average True Range (ATR) | 0.60 | 0.31 |
| MACD | -0.07 | 0.14 |
| Stochastic Oscillator | 57.47 | 81.04 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.